Prot #NU COH21S03: A Phase II Study of Cabozantinib and Temozolomide in Patients with Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas

Project: Research project

Project Details

StatusActive
Effective start/end date3/3/22 → 3/3/25

Funding

  • City of Hope National Medical Center (Prot #NU COH21S03)
  • Exelixis Inc. (Prot #NU COH21S03)